Citicoline is a compound your body naturally produces to build and repair brain cell membranes. When taken as a supplement, it breaks down into two components, choline and cytidine, which are absorbed and then reassembled in the brain. There, they fuel the production of phosphatidylcholine, a critical building block of the membranes surrounding every neuron. This process supports brain cell integrity, neurotransmitter production, and nerve signaling throughout the body.
How Citicoline Works in the Brain
Your brain cell membranes are made largely of phosphatidylcholine. Citicoline is the key intermediate your body uses to manufacture it. When you take citicoline orally, your gut breaks it into choline and cytidine, which travel through your bloodstream and cross into the brain. Once there, enzymes reassemble these pieces into citicoline, which then drives the production of phosphatidylcholine and other membrane components like sphingomyelin and cardiolipin.
This matters because healthy membranes keep neurons functioning properly. Damaged or degraded membranes impair everything from electrical signaling to nutrient transport. Citicoline appears to work on two fronts: it increases the synthesis of new membrane material and it helps prevent the breakdown of existing membranes by blocking enzymes that would otherwise chew them apart.
There’s also a self-preservation angle. When choline levels drop, neurons may strip phosphatidylcholine from their own membranes to produce acetylcholine, the neurotransmitter essential for memory and learning. Researchers call this “autocannibalism,” and it can accelerate neuronal degeneration over time. Supplemental citicoline provides an external source of choline, potentially sparing neurons from cannibalizing themselves.
Effects on Neurotransmitters
Because choline is the raw material for acetylcholine, citicoline is thought to support acetylcholine production. Animal studies have confirmed that citicoline increases acetylcholine levels in certain brain regions after traumatic injury. In aging rats given citicoline daily for seven months, muscarinic acetylcholine receptor density increased by 6 to 17 percent compared to controls whose receptor levels declined. More receptors means the brain can respond more effectively to its own acetylcholine signals.
Citicoline also influences dopamine, the neurotransmitter tied to motivation, pleasure, and movement. It doesn’t raise dopamine levels directly, but it appears to amplify dopamine signaling in two ways: by increasing the number of dopamine transporters in key brain areas and by boosting the amount of dopamine released when a neuron fires. In one animal study, oral citicoline increased stimulated dopamine release by 59 percent. This dopamine-enhancing effect is part of why citicoline has been explored as a supportive treatment in Parkinson’s disease.
Cognitive Performance and Mental Clarity
The neurotransmitter and membrane effects translate into measurable cognitive benefits in some studies. Citicoline has been tested across a range of doses, from 250 mg to 2,000 mg daily, in both healthy adults and people with neurological conditions. For healthy individuals, lower doses around 250 mg per day may provide more benefit than higher doses. Most clinical studies in patients with neurological disease have used 1,000 mg per day.
The cognitive effects people report, and that studies have measured, tend to center on attention, processing speed, and memory. These improvements likely stem from the combined effect of better membrane integrity (which improves the speed and reliability of nerve signaling) and increased availability of acetylcholine (which is central to forming and retrieving memories).
Neuroprotection After Stroke and Brain Injury
Citicoline has been studied extensively in stroke recovery. Its neuroprotective actions go well beyond membrane repair. During a stroke, a cascade of damaging events unfolds: cells become overexcited by glutamate (an excitatory chemical), energy reserves collapse, and inflammatory enzymes start breaking down cell structures. Citicoline intervenes at multiple points in this cascade.
It helps maintain cellular energy levels, blocks the release of destructive fatty acids, boosts the production of glutathione (the brain’s primary antioxidant), and increases the activity of glutathione reductase, an enzyme that recycles that antioxidant. It also enhances the brain’s ability to clear excess glutamate by increasing the number of glutamate transporters on astrocytes, the support cells that clean up the chemical environment around neurons. Less glutamate lingering outside cells means less excitotoxic damage.
In the chronic phase after a stroke, citicoline stimulates neuronal plasticity and improves sensorimotor recovery in animal models. In human trials, it is the only neuroprotective agent that has shown positive results across all randomized, double-blind trials and demonstrated efficacy in meta-analysis, with a safety profile similar to placebo. That consistency across trials is unusual for neuroprotective compounds, most of which have failed in human testing.
Effects on Vision and Glaucoma
Citicoline’s nerve-protecting properties extend to the eyes. Glaucoma damages retinal ganglion cells, the neurons that carry visual information from the eye to the brain along the optic nerve. Research from the National Eye Institute found that citicoline restored optic nerve signals between the brain and eye to near-normal levels in rats with glaucoma. Notably, it achieved this without reducing fluid pressure in the eye, which is the standard target of glaucoma treatment. This suggests citicoline works through a different, complementary mechanism: directly protecting the nerve cells rather than addressing the pressure that damages them.
Citicoline vs. Alpha-GPC
Alpha-GPC is the other popular choline supplement, and the two work differently. Alpha-GPC converts directly into free choline upon administration, skipping several metabolic steps that citicoline requires. This makes alpha-GPC more efficient at raising blood choline levels: it produces roughly twice the plasma choline concentration compared to citicoline (25.8 vs. 13.1 micromoles per liter).
However, citicoline provides something alpha-GPC does not. When citicoline breaks down, its cytidine component converts to uridine, which independently supports brain cell membrane synthesis and may contribute to acetylcholine production on its own. So citicoline offers a dual pathway: choline for neurotransmitter support and uridine for membrane building. If your primary goal is raising acetylcholine levels, alpha-GPC delivers more choline per dose. If you want broader membrane and neuroprotective support, citicoline covers more ground.
Dosage and Safety
Typical doses range from 250 to 1,000 mg per day. The European Food Safety Authority recommends a maximum of 500 mg daily for supplements and 1,000 mg daily for medical foods in middle-aged to elderly adults. Clinical trials have tested doses up to 2,000 mg daily without serious safety issues.
Side effects are uncommon and generally mild: digestive discomfort, transient headaches, and occasional restlessness. In one controlled trial of 74 participants, the citicoline group actually reported fewer adverse events (13) than the placebo group (28). Long-term use, studied for up to three years, shows a safety profile comparable to short-term supplementation. No serious safety issues have been reported across clinical trials.